Synergistic cofactor function of factor V and protein S to activated protein C in the inactivation of the factor VIIIa - factor IXa complex -- species specific interactions of components of the protein C anticoagulant system
- PMID: 9308749
Synergistic cofactor function of factor V and protein S to activated protein C in the inactivation of the factor VIIIa - factor IXa complex -- species specific interactions of components of the protein C anticoagulant system
Abstract
Human factor V has been shown not only to be a precursor to procoagulant factor Va but also to express anticoagulant properties. Thus, factor V was recently found to potentiate the effect of protein S as cofactor to activated protein C (APC) in the inactivation of the factor VIIIa-factor IXa complex. The purpose of this study was to determine whether the APC-cofactor function of factor V was also expressed in the bovine protein C system and to elucidate the molecular background for the species specificity of APC. For this purpose, the effects of protein S and factor V on APC-mediated inactivation of factor VIIIa were studied using purified APC, protein S and factor V of human and bovine origin. The factor VIIIa investigated here was part of a Xase complex (i.e. factor IXa, factor VIIIa, phospholipid and calcium) and the APC-mediated inhibition of factor VIIIa was monitored by the ability of the Xase complex to activate factor X. Synergistic APC-cofactor function of factor V and protein S was demonstrated in the bovine system. The effect of bovine APC was potentiated by bovine protein S but not by human protein S, whereas both human or bovine protein S stimulated the function of human APC. Factor V did not express species specificity in its APC-cofactor activity even though bovine factor V was more potent than its human counterpart. Recombinant human/bovine protein S chimeras were used to demonstrate that the thrombin sensitive region and first epidermal growth factor-like module of protein S determine the species specificity of the APC-protein S interaction. In conclusion, both human and bovine factor V were found to express APC-cofactor activity which depends on the presence of protein S. The species specificity of APC was shown to be caused by the interaction between APC and protein S.
Similar articles
-
C4b-binding protein inhibits the factor V-dependent but not the factor V-independent cofactor activity of protein S in the activated protein C-mediated inactivation of factor VIIIa.Thromb Haemost. 2001 May;85(5):761-5. Thromb Haemost. 2001. PMID: 11372664
-
Protein S down-regulates factor Xase activity independent of activated protein C: specific binding of factor VIII(a) to protein S inhibits interactions with factor IXa.Br J Haematol. 2008 Nov;143(3):409-20. doi: 10.1111/j.1365-2141.2008.07366.x. Epub 2008 Aug 28. Br J Haematol. 2008. PMID: 18759761
-
Factor V and protein S as cofactors to activated protein C.Haematologica. 1997 Jan-Feb;82(1):91-5. Haematologica. 1997. PMID: 9107093 Review.
-
The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa.Thromb Haemost. 2000 Aug;84(2):271-7. Thromb Haemost. 2000. PMID: 10959700
-
Protein C.Prog Hemost Thromb. 1984;7:25-54. Prog Hemost Thromb. 1984. PMID: 6099583 Review.
Cited by
-
Factor v deficiency associated with congenital cardiac disorder and intracranial hemorrage.Indian J Hematol Blood Transfus. 2013 Jun;29(2):99-101. doi: 10.1007/s12288-012-0149-8. Epub 2012 Mar 21. Indian J Hematol Blood Transfus. 2013. PMID: 24426348 Free PMC article.
-
Progress in the understanding of the protein C anticoagulant pathway.Int J Hematol. 2004 Feb;79(2):109-16. doi: 10.1532/ijh97.03149. Int J Hematol. 2004. PMID: 15005336 Review.
-
Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice.Nutr Metab (Lond). 2009 Aug 14;6:33. doi: 10.1186/1743-7075-6-33. Nutr Metab (Lond). 2009. PMID: 19678956 Free PMC article.
-
Modeling zymogen protein C.Biophys J. 2000 Dec;79(6):2925-43. doi: 10.1016/S0006-3495(00)76530-1. Biophys J. 2000. PMID: 11106601 Free PMC article.
-
Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen.Biomed Res Int. 2021 Oct 25;2021:7702863. doi: 10.1155/2021/7702863. eCollection 2021. Biomed Res Int. 2021. PMID: 34734086 Free PMC article. Review.